Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. - Wikidata - awgldk - TriplyDB

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

http://www.wikidata.org/entity/Q44253289

about

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy.Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.Treating irritable bowel syndrome: overview, perspective and future therapies.Gastric motor disturbances in patients with idiopathic rapid gastric emptying.Pharmacology of serotonin: what a clinician should know.Treatment of Functional Dyspepsia.Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis.Change in the Interstitial Cells of Cajal and nNOS Positive Neuronal Cells with Aging in the Stomach of F344 Rats Treatment of gastroparesis: a multidisciplinary clinical review.Current and emerging therapies for the management of functional gastrointestinal disorders.Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain.Impaired gastric accommodation and its role in dyspepsia Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.Associations between medication use and functional gastrointestinal disorders: a population-based study.Candidate genes and sensory functions in health and irritable bowel syndrome.High body mass alters colonic sensory-motor function and transit in humans.Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.Irritable bowel syndrome in psychiatric perspectives: a comprehensive review.Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Pharmacogenetics of low dose clonidine in irritable bowel syndrome.Serotonin in the gastrointestinal tract.The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review.Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.Serotonin: from top to bottom.An update on current pharmacotherapy options for dyspepsia.Drug-induced gastrointestinal disorders.Current and emerging pharmacotherapeutic options for irritable bowel syndrome.Centrally targeted pharmacotherapy for chronic abdominal pain.Common Functional Gastroenterological Disorders Associated With Abdominal Pain.The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice.Simplifying the measurement of gastric accommodation using SPECT.Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia.Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.Is the colonic response to food different in IBS in contrast to simple constipation or diarrhea without abdominal pain?Effects of the selective serotonin reuptake inhibitor, fluoxetine, on regional gastric contractility.Acute and chronic effects of desvenlafaxine on gastrointestinal transit and motility in dogs.A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

P2860

Q28301264-C6EAA3D9-8B5A-48AD-8CCD-AC9F009370BC Q33597733-4C3BB5E0-D9A2-4696-AB96-9B771C6F3BB2 Q33724343-C022262D-063E-4C2E-8311-8B51C8C544AA Q34318616-23191E5E-2C93-42AA-8367-0297F9DFB18D Q35047051-C649A3C3-C90C-4950-B471-B986817FB1E2 Q35053304-9FB94A95-BD77-48BD-B64F-34CB44DDBAF5 Q35596862-C2D938D0-FD49-448B-A963-79AD2BE5736B Q35686228-51FB15C6-0F12-4F85-967A-9CA840F2AADD Q36054184-DE25FD90-A450-4251-8462-990FF9E2EEC7 Q36238122-ADE9347F-72E3-4366-9362-11053D03B9A8 Q36428532-25362869-D257-43A4-8A57-7FCE0384E65A Q36443725-6BF0ABC1-545F-4D76-B02D-BB0D990D06E0 Q36455907-ECDAEF2C-EDA3-4403-A2A2-4FC68CDEDA71 Q36541253-D6C706B0-B5AD-4292-A036-F25CC9A08D72 Q36583822-F35300B6-3731-499E-9B9D-DE7696ECC678 Q36780776-B3779324-DAF3-4DB1-B6D6-1E86CD89F975 Q36846477-6CB252FE-8CB6-4E23-B6E0-796D1E49E77C Q36846509-5CFC1105-168B-48CA-980C-455F8FDC4A1F Q36874388-87C549AD-9CBE-48BF-B7C0-300BAAE12325 Q36945139-1749D6C6-5E37-42E3-95A9-4D5523B7361B Q37164063-C05C6782-51EA-4AD3-990B-D4B1A1519F6A Q37212893-D40381FF-14E3-4169-BDD6-94C92B7563C9 Q37223378-E2F51956-583D-4396-815A-D42EDAE63BB1 Q37678438-F0E31FFA-A8D3-445C-9164-43C6FAD49DD1 Q37700196-E7586A09-BF49-4F06-B4CA-6CBFC1767296 Q38055710-E63325FD-9607-45E7-B2A3-FD857E32B4B9 Q38115358-8F5FBD32-E169-4781-9D79-E6DE9C33F488 Q38221321-94AE8570-A310-4A13-B5B5-BFDA4A66D599 Q38254747-07654710-D729-4026-A021-D8528BE62C05 Q38343940-FF33B6FD-DCB9-4E6D-B5BA-53544F88C9E8 Q38919181-AED95329-0A64-4078-8C4F-537515CA0400 Q38960868-3D6F6C3A-E394-45AF-8260-646D7041D0DE Q40771921-36893C09-F83D-49C2-8C27-048D6686172B Q41274026-815C8C5D-1C3C-4877-850E-7D0999DA28D3 Q43235413-641C91A7-7C5B-482D-93E7-B19CD66896C3 Q43328445-7E9CBDBF-4F16-45CC-A49F-C3102E13213D Q45237975-6475467F-55F4-48EF-A6D2-D40746E2B404 Q45899139-E6DF7C79-52B2-4715-881B-3776A3000015 Q46120454-AC9EDE49-056D-4486-B8EA-C63B5BA299DF Q46173758-CBE9A97D-7413-4DCB-8953-79FBC33EAC4B

P2860

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

http://www.wikidata.org/entity/Q44253289

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Selective effects of serotoner ...... ntestinal functions in health.

@en

Selective effects of serotoner ...... ntestinal functions in health.

@nl

type

label

Selective effects of serotoner ...... ntestinal functions in health.

@en

Selective effects of serotoner ...... ntestinal functions in health.

@nl

prefLabel

Selective effects of serotoner ...... ntestinal functions in health.

@en

Selective effects of serotoner ...... ntestinal functions in health.

@nl

P1433

Q44253289-6A465ACA-DA67-451F-B22B-1F1AD878BD47

P1476

Q44253289-6BF3F367-9CE8-4958-B3D1-1808AA060C84

P2093

Q44253289-62731E78-C9F6-4297-8E10-42CD49E518D8

Q44253289-6782E698-9672-48FF-8619-A962FD289CFD

Q44253289-799F17D0-D487-4786-832F-0EE3DD7C75A6

Q44253289-A2767879-5F75-4B52-A094-488F7B85F243

Q44253289-E7602D6A-A22D-4BF3-BF5A-351419F04910

P2860

Q44253289-0938B1F2-0134-4539-BBEA-1887F8D3A9CA

Q44253289-158372FB-0CDB-4468-849C-4A46E84E99FD

Q44253289-1DE2F631-4E19-482D-89F1-2668DB23623A

Q44253289-2F213A7E-0D34-4FE6-AC05-386257D7E276

Q44253289-4A62D54B-5652-4AB3-8500-418D4065DE25

Q44253289-7F449BFD-344A-4E0B-A20F-F2552AC0EEEA

Q44253289-80A2D1D3-588A-4D55-BEBC-DDE1E299A70C

Q44253289-8B912335-460C-4E6F-ADB2-BDCB42AA6BE9

Q44253289-A765C5E4-324E-481A-8288-FAD7CAD52D38

Q44253289-AF7FFCC8-3A03-4A8F-B3A4-B1B00E6D0A2D

P304

Q44253289-EEC0358B-CC8A-4736-83A4-6239C82A2335

P31

Q44253289-0CC889DC-53EC-4852-8692-1D1E68F8A3DA

P356

Q44253289-C4A80C51-1E2E-4CF7-BB4A-597BBDBF38ED

P433

Q44253289-E84CD773-7B23-4B85-9460-D44903ACD79B

P478

Q44253289-40B19948-EAA2-4FD0-84AA-B69B91030CD8

P50

Q44253289-90025A12-63E7-40CA-9A74-AB74566A797D

P577

Q44253289-A6471C4C-64C3-4BEF-AC18-F968B4B8EA9F

P5875

Q44253289-ABFA05BA-75BC-44ED-868C-76357A736F5D

P698

Q44253289-3C7EB8CE-D42A-4F73-953E-BDDC660FAD85

P356

AJPGI.00266.2002

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Selective effects of serotoner ...... ntestinal functions in health.

@en

P2093

Debra Stephens

http://www.w3.org/2001/XMLSchema#string

Duane Burton

http://www.w3.org/2001/XMLSchema#string

George Thomforde

http://www.w3.org/2001/XMLSchema#string

Heather J Chial

http://www.w3.org/2001/XMLSchema#string

Kevin W Olden

http://www.w3.org/2001/XMLSchema#string

P2860

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug

Responses to gastric distension in functional dyspepsia.

Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function.

Towards a less costly but accurate test of gastric emptying and small bowel transit.

Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.

Buspirone inhibits corticotropin-releasing factor and stress-induced cecal motor response in rats by acting through 5-HT1A receptors.

Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.

P304

G130-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00266.2002

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10985958

http://www.w3.org/2001/XMLSchema#string

P698

12488239

http://www.w3.org/2001/XMLSchema#string